1218 related articles for article (PubMed ID: 26541316)
1. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
4. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
[TBL] [Abstract][Full Text] [Related]
5. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
6. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen.
Golsaz-Shirazi F; Amiri MM; Bahadori M; Bayat AA; Mohammadi H; Farid S; Maddah M; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Shokri F
Viral Immunol; 2015 Oct; 28(8):425-33. PubMed ID: 26425894
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product.
Usuda S; Okamoto H; Tanaka T; Kidd-Ljunggren K; Holland PV; Miyakawa Y; Mayumi M
J Virol Methods; 2000 Jun; 87(1-2):81-9. PubMed ID: 10856755
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen.
Qiu X; Schroeder P; Bridon D
J Immunol; 1996 May; 156(9):3350-6. PubMed ID: 8617960
[TBL] [Abstract][Full Text] [Related]
12. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
Wang W; Sun L; Li T; Ma Y; Li J; Liu Y; Li M; Wang L; Li C; Xie Y; Wen Y; Liang M; Chen L; Tong S
MAbs; 2016; 8(3):468-77. PubMed ID: 26713590
[TBL] [Abstract][Full Text] [Related]
13. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
Sobotta D; Sominskaya I; Jansons J; Meisel H; Schmitt S; Heermann KH; Kaluza G; Pumpens P; Gerlich WH
J Gen Virol; 2000 Feb; 81(Pt 2):369-78. PubMed ID: 10644835
[TBL] [Abstract][Full Text] [Related]
14. Construction and Characterization of an Anti-Hepatitis B Virus preS1 Humanized Antibody that Binds to the Essential Receptor Binding Site.
Wi J; Jeong MS; Hong HJ
J Microbiol Biotechnol; 2017 Jul; 27(7):1336-1344. PubMed ID: 28478661
[TBL] [Abstract][Full Text] [Related]
15. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays.
Kfoury Baz EM; Zheng J; Mazuruk K; Van Le A; Peterson DL
Transfus Med; 2001 Oct; 11(5):355-62. PubMed ID: 11696228
[TBL] [Abstract][Full Text] [Related]
17. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
[TBL] [Abstract][Full Text] [Related]
18. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
Karthigesu VD; Allison LM; Ferguson M; Howard CR
J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination.
Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
[TBL] [Abstract][Full Text] [Related]
20. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.
Usuda S; Okamoto H; Iwanari H; Baba K; Tsuda F; Miyakawa Y; Mayumi M
J Virol Methods; 1999 Jun; 80(1):97-112. PubMed ID: 10403681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
